| Primary |
| Product Used For Unknown Indication |
23.6% |
| Drug Use For Unknown Indication |
22.2% |
| Pain |
8.3% |
| Suicide Attempt |
8.3% |
| Arthralgia |
4.2% |
| Back Pain |
4.2% |
| Hiv Test Positive |
4.2% |
| Hypertension |
4.2% |
| Juvenile Arthritis |
2.8% |
| Pyrexia |
2.8% |
| Toothache |
2.8% |
| Ankylosing Spondylitis |
1.4% |
| Contusion |
1.4% |
| Dental Operation |
1.4% |
| Depressed Mood |
1.4% |
| Depression |
1.4% |
| Dysmenorrhoea |
1.4% |
| Fear |
1.4% |
| Hiv Infection |
1.4% |
| Hypercholesterolaemia |
1.4% |
|
| Renal Failure |
12.0% |
| Vomiting |
12.0% |
| Stevens-johnson Syndrome |
8.0% |
| Acute Generalised Exanthematous Pustulosis |
4.0% |
| Angioedema |
4.0% |
| Gastric Perforation |
4.0% |
| Gastric Ulcer |
4.0% |
| Gastrointestinal Haemorrhage |
4.0% |
| Haemofiltration |
4.0% |
| Liver Function Test Abnormal |
4.0% |
| Medication Error |
4.0% |
| Multiple Drug Overdose Intentional |
4.0% |
| Pain |
4.0% |
| Pericarditis |
4.0% |
| Pyrexia |
4.0% |
| Renal Disorder |
4.0% |
| Renal Impairment |
4.0% |
| Renal Tubular Necrosis |
4.0% |
| Respiratory Failure |
4.0% |
| Sepsis |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
68.1% |
| Pain |
4.9% |
| Suicide Attempt |
3.8% |
| Ischaemic Heart Disease Prophylaxis |
3.2% |
| Unevaluable Event |
2.7% |
| Depression |
2.2% |
| Bursitis |
1.6% |
| Dyslipidaemia |
1.6% |
| Functional Gastrointestinal Disorder |
1.6% |
| Plasma Cell Myeloma |
1.6% |
| Diabetes Mellitus |
1.1% |
| Fibromyalgia |
1.1% |
| Pain In Extremity |
1.1% |
| Periarthritis |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Ulcer |
1.1% |
| Analgesia |
0.5% |
| Analgesic Therapy |
0.5% |
| Anxiety |
0.5% |
| Anxiety Disorder |
0.5% |
|
| Toxicity To Various Agents |
22.0% |
| Colitis Microscopic |
9.8% |
| Renal Failure Acute |
9.8% |
| Vaginal Haemorrhage |
7.3% |
| Vomiting |
7.3% |
| Increased Tendency To Bruise |
4.9% |
| Suicide Attempt |
4.9% |
| Tremor |
4.9% |
| Drug Interaction |
2.4% |
| Gastritis |
2.4% |
| Haematemesis |
2.4% |
| Infection |
2.4% |
| Intestinal Perforation |
2.4% |
| Malaise |
2.4% |
| Musculoskeletal Chest Pain |
2.4% |
| Perforated Ulcer |
2.4% |
| Ph Body Fluid Abnormal |
2.4% |
| Product Quality Issue |
2.4% |
| Pulmonary Embolism |
2.4% |
| Pyrexia |
2.4% |
|
| Concomitant |
| Multiple Sclerosis |
21.8% |
| Plasma Cell Myeloma |
10.0% |
| Product Used For Unknown Indication |
7.4% |
| Type 2 Diabetes Mellitus |
5.7% |
| Prostate Cancer Metastatic |
5.2% |
| Depression |
4.8% |
| Drug Use For Unknown Indication |
4.4% |
| Gait Disturbance |
4.4% |
| Relapsing-remitting Multiple Sclerosis |
4.4% |
| Hypertension |
3.9% |
| Chronic Myeloid Leukaemia |
3.5% |
| Immunodeficiency Common Variable |
3.5% |
| Osteoporosis |
3.5% |
| Osteoporosis Prophylaxis |
3.1% |
| Chronic Hepatitis C |
2.6% |
| Hormone Replacement Therapy |
2.6% |
| Peripheral T-cell Lymphoma Unspecified |
2.6% |
| Actinic Keratosis |
2.2% |
| Colorectal Cancer Metastatic |
2.2% |
| Hiv Infection |
2.2% |
|
| Urinary Tract Infection |
9.1% |
| White Blood Cell Count Decreased |
9.1% |
| Vision Blurred |
7.1% |
| Vomiting |
7.1% |
| Visual Impairment |
6.1% |
| Fatigue |
5.1% |
| Nausea |
5.1% |
| Pneumonia |
5.1% |
| Tinnitus |
5.1% |
| Multiple Sclerosis Relapse |
4.0% |
| Pain |
4.0% |
| Pancreatitis Acute |
4.0% |
| Pyrexia |
4.0% |
| Somnolence |
4.0% |
| Stress Fracture |
4.0% |
| Unresponsive To Stimuli |
4.0% |
| Weight Decreased |
4.0% |
| Diarrhoea |
3.0% |
| Headache |
3.0% |
| Hypersensitivity |
3.0% |
|
